Journal of travel medicine
-
50-word teaser: COVID-19 is with us indefinitely and air travel is a necessity. Needed research has lagged due to pandemic disruption but must not stall due to COVID indifference. A US government report proposes that national aviation authorities, not health agencies, take the lead. Research priorities and study designs are proposed.
-
International travel has resumed while the risk of SARS-CoV-2 persists, leading to consideration of medications that can treat or prevent Covid-19 when travellers become ill abroad. Nirmatrelvir-ritonavir, molnupiravir and tixagevimab-cilgavimab are available under Emergency Use Authorization or conditional approval. We discuss the potential application of these medications to protect travellers.